In an in vitro study using CYP-expressing microsomes, it was revealed that primarily
two enzymes, CYP2D6 and CYP3A4, were involved in the metabolism of luliconazole,
and the metabolites in animals and humans were similar. After single and multiple
percutaneous applications of cream formulation in rats, radioactivity mainly resided on
the application site in the horny layer of skin. There was almost no metabolism of
luliconazole in the skin.